Post
Debiopharm doses first patient in Phase I trial of cancer combo therapy
Debiopharm has dosed the first patient in a Phase I clinical trial of Debio 0123 combined with carboplatin and etoposide …
Cora highlights data for DNA protecting supplement
Cora Therapeutics has reported positive clinical trial results for efficacy of Halo, an antioxidant supplement, in safeguarding DNA from radiation …
Merck and Eisai tease results for renal carcinoma treatment
Eisai and Merck & Co Inc (MSD) will present data at the American Society of Clinical Oncology (ASCO) meeting from …
Reece Pharmaceuticals onboards outpatient nurses from Ascott for DFI clinical trial
Reece Pharmaceuticals has onboarded outpatient nurses from healthcare provider Ascott, an IQVIA Company, to support its R327 diabetic foot infection …
The future of long Covid trials
Although there continues to be an increase in Covid-19 cases and deaths all around the world, the increase in 2023 …
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Hansa starts dosing in Phase III trial in anti-GBM disease
Hansa Biopharma has dosed the first patient in a pivotal Phase III trial investigating imlifidase in patients with anti-glomerular basement …
Immutep selects Charles River to conduct toxicology study for IMP761
Immutep has selected Charles River Laboratories to conduct a Good Laboratory Practice (GLP) toxicology study of its proprietary preclinical candidate …
Alzinova doses first patient in extension part of Phase Ib ALZ-101 trial
Alzinova has dosed the first patient in the extension part of its ongoing Phase Ib study of ALZ-101 to treat …
Alterity initiates new Phase II advanced MSA therapy trial
Alterity Therapeutics has started a new Phase II clinical trial of ATH434 for the treatment of Multiple System Atrophy (MSA), …
Sinovac Biotech gets approval for clinical trial of Covid-19 injection
Sinovac Biotech, a provider of biopharmaceutical products, has secured approval to undertake clinical trial in the country for its anti-Covid-19 …
Pipeline Moves: Novo Nordisk Phase III semaglutide completion bumps approval prospects
This week on Pipeline Moves, we start the week by looking at the completion of the Phase III trial investigating …
Amplia reports AMP945 data in preclinical model of pancreatic cancer
Amplia Therapeutics has reported data demonstrating the efficacy of AMP945 in a preclinical model of pancreatic cancer when used along …
Abbisko reports updated results from TGCT Phase Ib study
Abbisko Therapeutics has reported updated results from a Phase Ib study of Pimicotinib (ABSK021) for the treatment of advanced tenosynovial …
AstraZeneca reports positive results from endometrial cancer therapy trial
AstraZeneca has reported positive high-level results from the DUO-E trial (GOG 3041/ENGOT-EN10) of Imfinzi (durvalumab) and platinum-based chemotherapy combination followed …
Harbour reports results from HCC combo therapy trial
Harbour BioMed has reported results from a Phase Ib clinical trial of porustobart (HBM4003) combined with toripalimab for the treatment …